KEV 2026.09.231,721 entries+8 in 7d8 open federal deadlinesas of / search ? keys
Telemetry

Product / Oracle

Oracle Java Runtime Environment (JRE) in CISA KEV

Catalog
2026.09.23
Vendor
Oracle
Updated
2022-05-25

Answer CISA's KEV catalog lists 4 vulnerabilities in Oracle Java Runtime Environment (JRE) as of catalog 2026.09.23, 8.7% of Oracle's 46 entries. First added 2022-05-25, latest 2022-05-25; 2 ransomware-linked.

KEV entries
4
Ransomware: known
250%
First added
2022-05-25
Latest added
2022-05-25
Median days to due
21
Open deadlines
0federal

TAdditions by year

Oracle Java Runtime Environment (JRE) KEV additions per yearColumn chart of KEV additions per calendar year. 2021: 0; 2022: 4; 2023: 0; 2024: 0; 2025: 0; 2026: 0.012342021: 0 added20212022: 4 added420222023: 0 added20232024: 0 added20242025: 0 added20252026: 0 added (year to date)2026
Oracle Java Runtime Environment (JRE) KEV additions by year
YearAdded
20210
20224
20230
20240
20250
20260

WWeaknesses

CWEs in Oracle Java Runtime Environment (JRE) KEV entries
CWEEntriesShare
CWE-264 Permissions and access controls (category)125%

EAll entries

Oracle Java Runtime Environment (JRE) entries in CISA KEV
CVEVulnerabilityAddedDueRansomwareCWE
CVE-2013-2423Oracle JRE Unspecified VulnerabilityUnknownnone listed
CVE-2013-0431Oracle JRE Sandbox Bypass VulnerabilityKnownnone listed
CVE-2013-0422Oracle JRE Remote Code Execution VulnerabilityKnownCWE-264
CVE-2010-0840Oracle JRE Unspecified VulnerabilityUnknownnone listed

Cite this

CISA's KEV catalog lists 4 vulnerabilities in Oracle Java Runtime Environment (JRE). Source: Telemetry analysis of the CISA Known Exploited Vulnerabilities catalog, version 2026.09.23 (released 2026-09-23). https://glide-telemetry.pages.dev/products/oracle-java-runtime-environment-jre/

Source: CISA KEV catalog v2026.09.23, released 2026-09-23. Windows end 2026-09-23.

Keyboard shortcuts

Keyboard shortcuts
/Focus search
?Show this panel
EscClose panel or clear search
g dGo to Dashboard
g kGo to KEV
g vGo to Vendors
g pGo to Products
g wGo to Weaknesses
g sGo to Stats
g rGo to Regulations
g bGo to Briefings
g aGo to API